Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohortNadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Journal of Geophysical Research. Oceans|August 21, 2020
Net primary productivity estimates and environmental variables in the Arctic Ocean: An assessment of coupled physical-biogeochemical modelsYounjoo J Lee, Patricia A Matrai, Marjorie A M Friedrichs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2025
Structural and functional connectivity in tau mutation carriers: from presymptomatic to symptomatic frontotemporal dementiaArabella Bouzigues, Vincent Le Du, Matthieu Joulot, et al.
International Archives of Allergy and Immunology|February 10, 2021
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
International Archives of Allergy and Immunology|December 22, 2020
Spices to Control COVID-19 Symptoms: Yes, but Not Only…Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
Nature Communications|July 14, 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersAnthony Ferrari, Anne Vincent-Salomon, Xavier Pivot, et al.
Cell|October 10, 2015
Reconstruction and Simulation of Neocortical MicrocircuitryHenry Markram, Eilif Muller, Srikanth Ramaswamy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trialClément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, et al.
Pageof 32